Physician profile
Arunkumar N Badi
NPI 1225123938
$1,469.24
in general payments reported to CMS, 2019-2025
20 companies · $201 in 2025
The $201 reported for 2025 was less than what a typical Sleep Medicine (Otolaryngology) provider received nationally (typical 2025 total: $509).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.43 · 2020: $198 · 2021: $311 · 2022: $312 · 2023: $185 · 2024: $180 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $566.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $257.89 | 2019-2025 | Clarifix, Audion Et Dilation System |
| Novo Nordisk INC | $245.61 | 2021-2024 | Wegovy |
| Lilly USA, LLC | $149.61 | 2025 | Zepbound |
| Cerapedics INC. | $140.84 | 2022 | |
| Itamar Medical INC | $116.76 | 2023 | Watchpatone |
| Harmony Biosciences LLC | $112.32 | 2020-2023 | Wakix |
| Biohaven Pharmaceuticals, INC. | $88.92 | 2020 | |
| Jazz Pharmaceuticals INC. | $55.08 | 2020-2022 | |
| Medtronic, INC. | $50.29 | 2024-2025 | Propel |
| Acclarent, INC | $45.02 | 2019-2023 | Relieva Tract |
| Olympus America INC. | $33.68 | 2021 | |
| Phadia US INC. | $31.21 | 2021-2023 | Immunocap |
| Regeneron Healthcare Solutions, INC. | $30.52 | 2021 | |
| Genzyme Corporation | $25.75 | 2022 | |
| Alk-Abello, INC | $19.56 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $15.10 | 2019 | |
| Ambu INC. | $14.25 | 2023 | |
| Glaxosmithkline, LLC. | $12.42 | 2022 | |
| Sanofi-Aventis U.S. LLC | $12.40 | 2019 | |
| Resmed Corp | $12.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arunkumar Badi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.